vimarsana.com

Page 68 - எங்களுக்கு ப்ரெவெஂடிவ் சேவைகள் பணி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): a randomised, double-blind, placebo-controlled primary prevention trial

Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): a randomised, double-blind, placebo-controlled primary prevention trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

Delaying colonoscopy following abnormal stool test increases risk of colorectal cancer

 E-Mail IMAGE: Study co-author Dr. Samir Gupta, chief of gastroenterology at the VA San Diego Healthcare System, says some patients and primary care providers misunderstand the results of abnormal stool blood screening. view more  Credit: Christopher Menzie A new Veterans Affairs study finds that delays in undergoing colonoscopy following an abnormal stool test increase the risk of a colorectal cancer diagnosis and cancer-related death. The results appeared online in the journal Gastroenterology in January 2021. In a retrospective study of more than 200,000 Veterans, the researchers found that patients who received colonoscopy more than 13 months after an abnormal stool blood test were up to 1.3 times more likely to have colorectal cancer, compared with those who had colonoscopy up to three months after the stool test. Odds of an advanced stage of cancer at diagnosis were up to 1.7 times higher when colonoscopy was delayed beyond 16 months.

Dr Daniel Kopans: Will the USPSTF heed science on breast screening?

Dr. Daniel Kopans. The history of the U.S. Preventive Services Task Force (USPSTF) on breast screening is another case in point, in which decisions on mammography guidelines have been based on flawed analyses of scientific data. When the USPSTF last week opened a new review of breast screening guidelines, it created the opportunity to revisit the group s flawed decision in 2009 to not recommend breast screening for women in their 40s. However, a number of factors need to be addressed for the 2021 review to present a fair and impartial review of the science and evidence in favor of breast screening.

What to expect with telehealth and healthcare technology in the next 4 years

INTRO COMMENTS: Hello and welcome to Modern Healthcare’s Next Up, the podcast for emerging healthcare leaders. My name is Kadesha Smith, I'm your host. I’m also the CEO of CareContent, a digital strategy agency for healthcare organizations. Welcome back from the holiday break, welcome back to…

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.